Adamas Pharmaceuticals Inc Contracts & Agreements

75 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Compensation arrangements with Executive Officers
Compensation Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2021
Agreement and Plan of Merger, dated as of October 10, 2021, by and among Supernus, Supernus Reef, Inc. and Adamas Pharmaceuticals, Inc
Merger Agreements
Adamas Pharmaceuticals Inc
2021
First Amendment to Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC
Purchase Agreements
Adamas Pharmaceuticals Inc
2021
Binding Term Sheet by and between Adamas Pharma, LLC and Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA) Inc
Term Sheets
Adamas Pharmaceuticals Inc
2021
Form of Performance Restricted Stock Unit Grant Notice and Award Agreement
Bonus & Incentive Agreements
Adamas Pharmaceuticals Inc
2021
Underwriting Agreement, dated February 24, 2021, by and between the Company and SVB Leerink LLC and William Blair & Company, L.L.C., as representatives of the underwriters named...
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2021
Asset Purchase Agreement by and between Adamas Pharmaceuticals, Inc. and Osmotica Pharmaceutical US LLC
Purchase Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2021
Adamas Pharmaceuticals, Inc. Amended and Restated 2016 Inducement Plan
Adamas Pharmaceuticals Inc
Biotechnology
DE
2021
Adamas Pharmaceuticals, Inc. Amended and Restated Executive Severance Plan
Severance Agreements
Adamas Pharmaceuticals Inc
2021
Amendment No. 3 to the Loan Agreement dated December 1, 2020 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2021
Extension to Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Rajiv Patni, dated July 15, 2020
Consulting Agreements
Adamas Pharmaceuticals Inc
2020
Adamas Pharmaceuticals, Inc. Amended and Restated 2016 Inducement Plan
Adamas Pharmaceuticals Inc
2020
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Jennifer Rhodes, dated January 9, 2020
Consulting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2020
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Rajiv Patni, dated February 25, 2020
Consulting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2020
2020 Compensation actions with respect to Non-Employee Directors
Compensation Agreements
Adamas Pharmaceuticals Inc
2020
Description of Capital Stock
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2020
Adamas Pharmaceuticals, Inc. Amended and Restated 2016 Inducement Plan
Adamas Pharmaceuticals Inc
2020
Amendment No. 2 to the Loan Agreement dated January 2, 2020 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2020
Binding Term Sheet by and between Adamas Pharma, LLC and Sandoz, Inc
Term Sheets
Adamas Pharmaceuticals Inc
2020
Separation and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Alfred G. Merriweather, dated August 7, 2019
Consulting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2019
Transition, separation, and consulting agreement by and between Adamas Pharmaceuticals, Inc. and Gregory T. Went, Ph.D., dated September 11, 2019
Consulting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2019
Employment Offer by and between Adamas Pharmaceuticals, Inc. and Neil F. McFarlane, dated September 12, 2019
Employment Agreements
Adamas Pharmaceuticals Inc
2019
Offer Letter by and between Adamas Pharmaceuticals, Inc. and Vijay Shreedhar, Ph.D., dated May 14, 2019
Adamas Pharmaceuticals Inc
Biotechnology
CA
2019
First Amendment to Amended and Restated Commercial Supply Agreement by and between Adamas Pharmaceuticals, Inc. and Catalent Pharma Solutions, LLC
Supply Agreements
Adamas Pharmaceuticals Inc
2019
Adamas Pharmaceuticals, Inc. Amended and Restated 2016 Inducement Plan
Adamas Pharmaceuticals Inc
Biotechnology
DE
2019
Eighth Amendment to Lease by and between the registrant and KBSIII Towers At Emeryville, LLC, dated as of August 2, 2018
Lease Agreements
Adamas Pharmaceuticals Inc
2018
Separation and consulting agreement by and between the registrant and Richard A. King, dated September 13, 2018
Consulting Agreements
Adamas Pharmaceuticals Inc
2018
2018 compensation actions with respect to Non-Employee Directors
Compensation Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2018
Secured Promissory Note dated November 27, 2017 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Note Agreements
Adamas Pharmaceuticals Inc
2018
Seventh Amendment to Lease by and between the registrant and KBSIII Towers At Emeryville, LLC, dated as of January 16, 2018
Lease Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2018
Underwriting Agreement, dated January 23, 2018, by and among the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Leerink Partners LLC, and Evercore Group L.L.C.,...
Underwriting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2018
Amended and Restated Commercial Supply Agreement by and between Adamas Pharmaceuticals, Inc. and Catalent Pharma Solutions, LLC
Supply Agreements
Adamas Pharmaceuticals Inc
2017
Amended and Restated API Supply Agreement by and between Adamas Pharma, LLC and Moehs Ibrica, S.L
Supply Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2017
Offer Letter by and between the registrant and Richard A. King, dated April 17, 2017
Adamas Pharmaceuticals Inc
Biotechnology
CA
2017
Offer Letter by and between the registrant and Alfred G. Merriweather, dated June 26, 2017
Adamas Pharmaceuticals Inc
Biotechnology
CA
2017
Separation Agreement by and between the registrant and William Dawson, dated June 27, 2017
Separation Agreements
Adamas Pharmaceuticals Inc
2017
Loan Agreement dated May 11, 2017 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Loan Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2017
Secured Promissory Note dated May 11, 2017 between Adamas Pharma, LLC and Healthcare Royalty Partners III, L.P
Note Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2017
ADAMAS PHARMACEUTICALS, INC. $50,000,000 COMMON STOCK SALES AGREEMENT
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
NY
2017
Amended and Restated Adamas Pharmaceuticals, Inc. Executive Severance Plan
Severance Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2017
2017 Executive Cash Bonus Award Program
Bonus & Incentive Agreements
Adamas Pharmaceuticals Inc
2017
AnnualAnnualChairMemberCommitteeFeeFeeAudit Committee$15,000 $7,500 Compensation Committee$10,000 $5,000 Nominating and Corporate Governance Committee$7,000 $3,500 Development...
Compensation Agreements
Adamas Pharmaceuticals Inc
2017
CONSULTING SERVICES AGREEMENT
Consulting Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2016
1900 Powell St. Suite 750 Emeryville, CA 94608 Tel ###-###-#### Fax ###-###-#### www.adamaspharma.com
Adamas Pharmaceuticals Inc
Biotechnology
CA
2016
2016 Executive Cash Bonus Award Program
Bonus & Incentive Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2016
SIXTH AMENDMENT TO LEASE
Lease Agreements
Adamas Pharmaceuticals Inc
2016
ADAMAS PHARMACEUTICALS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Adamas Pharmaceuticals Inc
2016
2,500,000 Shares ADAMAS PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Adamas Pharmaceuticals Inc
2016
1900 Powell St. Suite 750 Emeryville, CA 94608 Tel ###-###-#### Fax ###-###-#### www.adamaspharma.com
Adamas Pharmaceuticals Inc
Biotechnology
CA
2015
ADAMAS PHARMACEUTICALS INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE
Bonus & Incentive Agreements
Adamas Pharmaceuticals Inc
2015
2200 Powell St. Suite 220 Emeryville, CA 94608 Tel ###-###-#### Fax ###-###-#### www.adamaspharma.com
Adamas Pharmaceuticals Inc
Biotechnology
CA
2015
2200 Powell St. Suite 220 Emeryville, CA 94608 Tel ###-###-#### Fax ###-###-#### www.adamaspharma.com
Adamas Pharmaceuticals Inc
Biotechnology
CA
2014
EXHIBIT A Confidential Information and Invention Assignment Agreement
Assignment Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2014
FIFTH AMENDMENT TO LEASE
Lease Agreements
Adamas Pharmaceuticals Inc
2014
ADAMAS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: MARCH 23, 2014 IPO DATE/EFFECTIVE DATE:...
Bonus & Incentive Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
LICENSE AGREEMENT BY AND BETWEEN FOREST LABORATORIES HOLDINGS LIMITED AND ADAMAS PHARMACEUTICALS, INC. DATED AS OF NOVEMBER 13, 2012
License Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2014
ADAMAS PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: MARCH 23, 2014
Stock Agreements
Adamas Pharmaceuticals Inc
2014
[] Shares Adamas Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Adamas Pharmaceuticals Inc
2014
NEUROMOLECULAR, INC. 2002 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
ADAMAS PHARMACEUTICALS, INC. 2007 STOCK PLAN ADOPTED ON DECEMBER 12, 2007 AMENDED THROUGH SEPTEMBER 3, 2013
Stock Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
ADAMAS PHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: , 2014 IPO DATE/EFFECTIVE DATE: , 2014
Bonus & Incentive Agreements
Adamas Pharmaceuticals Inc
2014
ADAMAS PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: FEBRUARY 20, 2014 APPROVED BY THE STOCKHOLDERS: , 2014
Stock Agreements
Adamas Pharmaceuticals Inc
2014
ADAMAS PHARMACEUTICALS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT June 30, 2011
Investor Rights Agreements
Adamas Pharmaceuticals Inc
Biotechnology
DE
2014
LICENSE AGREEMENT BY AND BETWEEN FOREST LABORATORIES HOLDINGS LIMITED AND ADAMAS PHARMACEUTICALS, INC. DATED AS OF NOVEMBER 13, 2012
License Agreements
Adamas Pharmaceuticals Inc
Biotechnology
CA
2014
WATERGATE OFFICE TOWERS EMERYVILLE TOWER 1 EMERYVILLE, CALIFORNIA OFFICE LEASE AGREEMENT BETWEEN CA-EMERYVILLE PROPERTIES LIMITED PARTNERSHIP, a Delaware limited partnership...
Lease Agreements
Adamas Pharmaceuticals Inc
2014
FIRST AMENDMENT TO LEASE
Lease Agreements
Adamas Pharmaceuticals Inc
2014
SECOND AMENDMENT TO OFFICE LEASE AGREEMENT
Lease Agreements
Adamas Pharmaceuticals Inc
2014
THIRD AMENDMENT TO LEASE
Lease Agreements
Adamas Pharmaceuticals Inc
2014
FOURTH AMENDMENT TO LEASE
Lease Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2014
1900 Powell St., Suite 210 Emeryville, CA 94608 Office: 510 ###-###-#### Fax ###-###-####
Adamas Pharmaceuticals Inc
2014
2200 Powell St. Suite 220 Everyville, CA 94608 Tel | 510 ###-###-#### Fax | 510 ###-###-#### www.adamaspharma.com
Adamas Pharmaceuticals Inc
2014
2200 Powell St. Suite 220 Emeryville, CA 94608 Tel ###-###-#### Fax ###-###-#### www.adamaspharma.com
Adamas Pharmaceuticals Inc
Biotechnology
CA
2014
ADAMAS PHARMACEUTICALS, INC. INDEMNITY AGREEMENT
Adamas Pharmaceuticals Inc
2014
ADAMAS PHARMACEUTICALS, INC. TRANSACTION BONUS PLAN
Bonus & Incentive Agreements
Adamas Pharmaceuticals Inc
2014
Adamas Pharmaceuticals, Inc. Executive Severance Plan
Severance Agreements
Adamas Pharmaceuticals Inc
Biotechnology
2014